VEGFR2 Antibody [KDR721]

• Background:

  VEGFR2 (also called CD309, KDR3, and Flk-1) is a type I transmembrane glycoprotein and is mainly expressed by endothelial cells, embryonic tissues, and megakaryocytes. As a receptor for VEGF proteins, it plays an important role in the regulation of angiogenesis, vasculogenesis, and vascular permeability.

• NCBI Gene ID:

  3791

• Swiss Prot:

  P35968

• Host:

  Mouse

• Reactivity:

  Human

• Immunogen:

  Recombinant human VEGFR2 protein was used as the immunogen for this antibody.

• Clonality:

  Monoclonal

• Clone:

  KDR721

• Conjugation:

  Unconjugated

• Type:

  Primary Antibodies

• Field of Research:

  Cancer, Immunology, Obesity, Signal Transduction

• Purification:

  Protein G affinity chromatography

• Concentration:

  0.2 mg/mL

• Buffer:

  PBS with 0.1 mg/ml BSA and 0.05% sodium azide

• Modification:

  None

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Aliquot and Store at 2-8˚ C. Avoid freez-thaw cycles.

• Fragment:

  IgG1, kappa

• Symbol:

  KDR

• NCBI Official Name:

  Kinase insert domain receptor (a type III receptor tyrosine kinase)

• NCBI Organism:

  Homo sapiens

• Other Product Names:

  Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, FLK-1, Kinase insert domain receptor, KDR, Protein-tyrosine kinase receptor flk-1, CD309, KDR, FLK1, VEGFR2

• Tested Applications:

  Flow, IF, Functional Assays

• Physical Properties:

  Liquid